Cytek Biosciences Inc (CTKB)
6.22
-0.05
(-0.80%)
USD |
NASDAQ |
May 09, 15:39
Cytek Biosciences Total Liabilities (Quarterly): 101.39M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 101.39M |
| September 30, 2023 | 103.91M |
| June 30, 2023 | 100.88M |
| March 31, 2023 | 101.12M |
| December 31, 2022 | 93.93M |
| September 30, 2022 | 82.79M |
| June 30, 2022 | 81.69M |
| Date | Value |
|---|---|
| March 31, 2022 | 78.44M |
| December 31, 2021 | 57.92M |
| September 30, 2021 | 51.12M |
| June 30, 2021 | 241.26M |
| March 31, 2021 | 239.02M |
| December 31, 2020 | 236.01M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
51.12M
Minimum
Sep 2021
241.26M
Maximum
Jun 2021
120.73M
Average
100.88M
Median
Jun 2023
Total Liabilities (Quarterly) Benchmarks
| Ainos Inc | 7.394M |
| OpGen Inc | 15.46M |
| Zomedica Corp | 13.18M |
| LENSAR Inc | 36.16M |
| Eargo Inc (DELISTED) | 24.62M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 494.46M |
| Shareholders Equity (Quarterly) | 393.06M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 6.973 |
| Net Debt Paydown Yield | -0.04% |